Abstract:BACKGROUND:Circulating tumor cells (CTCs) have shown prognostic relevance in many cancer types. However, the majority of current CTC capture methods rely on positive selection techniques that require a priori knowledge about the surface protein expression of disseminated CTCs, which are known to be a dynamic population. METHODS:We developed a microfluidic CTC capture chip that incorporated a nanoroughened glass substrate for capturing CTCs from blood samples. Our CTC capture chip utilized the differential adhesion preference of cancer cells to nanoroughened etched glass surfaces as compared to normal blood cells and thus did not depend on the physical size or surface protein expression of CTCs. RESULTS:The microfluidic CTC capture chip was able to achieve a superior capture yield for both epithelial cell adhesion molecule positive (EpCAM+) and EpCAM- cancer cells in blood samples. Additionally, the microfluidic CTC chip captured CTCs undergoing transforming growth factor beta-induced epithelial-to-mesenchymal transition (TGF-β-induced EMT) with dynamically down-regulated EpCAM expression. In a mouse model of human breast cancer using EpCAM positive and negative cell lines, the number of CTCs captured correlated positively with the size of the primary tumor and was independent of their EpCAM expression. Furthermore, in a syngeneic mouse model of lung cancer using cell lines with differential metastasis capability, CTCs were captured from all mice with detectable primary tumors independent of the cell lines' metastatic ability. CONCLUSIONS:The microfluidic CTC capture chip using a novel nanoroughened glass substrate is broadly applicable to capturing heterogeneous CTC populations of clinical interest independent of their surface marker expression and metastatic propensity. We were able to capture CTCs from a non-metastatic lung cancer model, demonstrating the potential of the chip to collect the entirety of CTC populations including subgroups of distinct biological and phenotypical properties. Further exploration of the biological potential of metastatic and presumably non-metastatic CTCs captured using the microfluidic chip will yield insights into their relevant differences and their effects on tumor progression and cancer outcomes.

Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging.

Capture and identification of heterogeneous circulating tumor cells using double antibodies capture system and quantum dots-based multiplexed imaging

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Nanoroughened Adhesion-Based Capture of Circulating Tumor Cells with Heterogeneous Expression and Metastatic Characteristics.

Rapid and efficient isolation and detection of circulating tumor cells based on ZnS:Mn 2+ quantum dots and magnetic nanocomposites.

Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles

High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (ctcs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles

Transparent, Biocompatible Nanostructured Surfaces for Cancer Cell Capture and Culture.

Effective Isolation, Label and Release of Multitype Circulating Tumor Cells Base on CdSe/ZnS Quantum Dots and Dual-antibody Modified Magnetic Nanoparticles

Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment

Chip-Assisted Single-Cell Biomarker Profiling of Heterogeneous Circulating Tumor Cells Using Multifunctional Nanospheres

Capture of Live Circulating Tumor Cells Via Unique Surface Charges from Cancer Patients by a Novel Nanotechnology

Homogeneous two-dimensional visual and fluorescence analysis of circulating tumor cells in clinical samples via steric hindrance regulated enzymes recognition cleavage and elongation

Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm.

Ph-Sensitive Dye-Based Nanobioplatform for Colorimetric Detection of Heterogeneous Circulating Tumor Cells.

Biocompatible TiO2 Nanoparticle-Based Cell Immunoassay for Circulating Tumor Cells Capture and Identification from Cancer Patients

Combination of Antibody-Coated, Physical-Based Microfluidic Chip with Wave-Shaped Arrays for Isolating Circulating Tumor Cells

Quantification of Rare Cancer Cells in Patients with Gastrointestinal Cancer by Nanostructured Substrate.

Combining hybrid cell membrane modified magnetic nanoparticles and inverted microfluidic chip for in situ CTCs capture and inactivation

Beyond enumeration: Phenotype independent “labeling-capture-release” process enabling precise detection of circulating tumour cells and downstream applications

Novel Nitrocellulose Membrane Substrate for Efficient Analysis of Circulating Tumor Cells Coupled with Surface-Enhanced Raman Scattering Imaging.